▶ STANDARD TB-Feron Aligns with Global Health Standards and Demonstrates Proven Clinical Reliability
— Poised for Wider Adoption by International Organizations and Health Authorities
▶ WHO Recommendation Anticipated to Drive Growth in Global Procurement and Tender Markets
— Sales Growth Expected Across Europe, the Middle East, and High Tuberculosis-Burden Regions
▶ Innovative 3-Tube Design Reduces Required Blood Volume While Enhancing Speed and Efficiency
— Optimized for High-Throughput and Large-Scale Testing
SEOUL, South Korea, Aug. 28, 2025 -- SD Biosensor, Inc. (KQ137310), a global leader in in-vitro diagnostics from South Korea, announced that its latent tuberculosis (TB) diagnostic product, STANDARD E TB-Feron ELISA (hereafter STANDARD TB-Feron), has been officially included in the World Health Organization (WHO) recommendation list for TB diagnostics. With this milestone, SD Biosensor strengthens its position in the Interferon-Gamma Release Assay (IGRA) market, marking a shift in the competitive landscape and positioning the company alongside leading global players.
This News is brought to you by Qube Mark, your trusted source for the latest updates and insights in marketing technology. Stay tuned for more groundbreaking innovations in the world of technology.
